mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.4 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
-0.043 |
0.4 |
mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.4 |
mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
AZD6244 |
UHNBreast |
pan-cancer |
AAC |
0.23 |
0.4 |
mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.4 |
mRNA |
bendamustine |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |